J. L. Badano and N. Katsani, Human genetics and disease: beyond Mendel: an evolving view of human genetic disease transmission, Nat Rev Genet, vol.3, issue.10, pp.779-790, 2002.

A. L. Barabási, Network medicine: from obesity to the "diseasome, N Engl J Med, vol.357, pp.404-407, 2007.

A. L. Barabási, N. Gulbahce, and J. Loscalzo, Network medicine: a network-based approach to human disease, Nat Rev Genet, vol.12, issue.1, pp.56-68, 2011.

G. P. Bates, History of genetic disease: the molecular genetics of Huntington disease -a history, Nat Rev Genet, vol.6, issue.10, pp.766-773, 2005.

P. Beurton, R. Falk, and H. J. Rheinberger, The concept of the gene in development and evolution. Historical and epistemological perspectives, 2000.

P. Braun, E. Rietman, and M. Vidal, Networking metabolites and diseases, Proc Natl Acad Sci, vol.105, issue.29, pp.9849-9850, 2008.

A. Caspi, J. Mcclay, and T. E. Moffitt, Role of genotype in the cycle of violence in maltreated children, Science, vol.297, pp.851-854, 2002.

S. Chen and G. Parmigiani, Meta-analysis of BRCA1 and BRCA2 penetrance, J Clin Oncol, vol.25, issue.11, pp.1329-1333, 2007.

Y. Chen, J. Zhu, and P. Y. Lum, Variations in DNA elucidate molecular networks that cause disease, Nature, vol.452, pp.429-435, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00283069

J. Dausset, Correlation between histocompatibility antigens and susceptibility to illness, Prog Clin Immunol, vol.1, pp.183-210, 1972.

J. Dausset, Predictive medicine, Eur J Obstet Gynaecol Reprod Biol, vol.65, pp.29-32, 1996.

C. Dekeuwer, Defining genetic disease, Classification, disease and evidence, pp.147-164, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01791752

K. M. Dipple and E. Mccabe, Modifier genes convert "simple" Mendelian disorders to complex traits, Mol Genet Metab, vol.71, pp.43-50, 2000.

C. J. Epstein, Medical genetics in the genomic medicine of the 21st century, Am J Hum Genet, vol.79, issue.3, pp.434-438, 2006.

T. M. Friebel, S. M. Domchek, and T. R. Rebbeck, Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis, J Natl Cancer Inst, vol.106, issue.6, pp.1-15, 2014.

D. J. Galas and L. Hood, Systems biology and emerging technologies will catalyze the transition from reactive medicine to predictive, personalized, preventive and participatory medicine, Interdiscip Biol Central, vol.1, issue.2, pp.1-4, 2009.

L. Gannett, What's in a cause? The pragmatic dimensions of genetic explanations, Biol Philos, vol.14, pp.349-374, 1999.

F. Gifford, Genetic traits, Biol Philos, vol.5, issue.3, pp.327-347, 1990.

A. M. Hedgecoe, Reinventing diabetes: classification, division and the geneticization of disease, New Genet Soc, vol.21, issue.1, pp.7-27, 2002.

A. M. Hedgecoe, Expansion and uncertainty: cystic fibrosis, classification and genetics, Sociol Health Illn, vol.25, issue.1, pp.50-70, 2003.

G. Hesslow, What is a genetic disease? On the relative importance of causes, pp.183-193, 1984.

G. Hesslow, The problem of causal selection. In: Hilton DJ (ed) Contemporary science and natural explanation: commonsense conceptions of causality, pp.11-31, 1988.

R. Hoedemaekers, T. Have, and H. , Geneticization: the Cyprus paradigm, J Med Philos, vol.23, issue.3, pp.274-287, 1998.

L. Hood, Systems biology and the New technologies enable predictive and preventative medicine, Science, vol.306, issue.5696, pp.640-643, 2004.

L. Hood and M. Flores, A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized, and participatory, N Biotechnol, vol.29, issue.6, pp.613-624, 2012.

A. Kerr, Giving up on geneticization: a comment on Hedgecoe's "Expansion and uncertainty: cystic fibrosis, classification and genetics, Sociol Health Illn, vol.26, issue.1, pp.102-106, 2004.

A. Kerr, Understanding genetic disease in a socio-historical context: a case study of cystic fibrosis, Sociol Health Illn, vol.27, issue.7, pp.873-896, 2005.

P. Kitcher, Battling the undead. How (and how not) to resist genetic determinism, Kitcher P (ed) In Mendel's mirror. Philosophical reflections on biology, pp.283-300, 2003.

R. C. Lewontin, The triple helix: gene, organism and environment, 2000.

A. Lippman, Prenatal genetic testing and screening: constructing needs and reinforcing inequalities, Am J Law Med, vol.17, pp.11-50, 1991.

J. Loscalzo, I. Kohane, and A. L. Barabási, Human disease classification in the postgenomic era: a complex system approach to human pathobiology, Mol Syst Biol, vol.3, issue.1, pp.1-11, 2007.

D. Magnus, (eds) Health, disease, and illness: concepts in medicine, pp.233-242, 2004.

T. A. Manolio, F. S. Collins, and N. J. Cox, Finding the missing heritability of complex diseases, Nature, vol.461, issue.7265, pp.747-753, 2009.

S. Misra, Human gene therapy: a brief overview of the genetic revolution, JAPI, vol.61, pp.127-133, 2013.

D. Nelkin and M. S. Lindee, (eds) Health, disease, and causal explanations in medicine, Ann Arbor Norell S, 1984.

S. Oyama, The ontogeny of information: developmental systems and evolution, Trends Genet, vol.17, issue.9, pp.502-510, 1985.

G. D. Smith, Establishing medical reality -essays in the metaphysics and epistemology of biomedical science, pp.83-110, 2007.

J. Tabery, Biometric and developmental gene-environment interactions: looking back, moving forward », Dev Psychopathol, vol.19, issue.4, pp.961-976, 2007.

J. Tabery, From a genetic predisposition to an interactive predisposition: rethinking the ethical implications of screening for gene-environment interactions, J Med Philos, vol.34, issue.1, pp.27-48, 2009.

, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, vol.447, pp.661-678, 2007.

P. M. Visscher, M. A. Brown, and M. I. Mccarthy, Five years of GWAS discovery, Am J Hum Genet, vol.90, issue.1, pp.7-24, 2012.

X. Zhou, J. Menche, and A. L. Barabási, Human symptoms-disease network, Nat Commun, vol.5, pp.1-10, 2014.

, Online Resources

, Gene Therapy Clinical Trial Worldwide, 2015.

, Online Inheritance in Man, 2015.